TSD Life Sciences Co.,Ltd. announced a private placement of 112,359 common shares at a price of KRW 26,700 for gross proceeds of KRW 2,999,985,300 on May 17, 2021. The transaction included participation from Cytogen, Inc. The transaction is expected to close on May 21, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11,250 KRW | 0.00% | -9.93% | -16.79% |
1st Jan change | Capi. | |
---|---|---|
-16.79% | 184M | |
-27.67% | 9.87B | |
-17.30% | 2.74B | |
-11.15% | 2.24B | |
-22.32% | 1.63B | |
+59.69% | 1.39B | |
+23.58% | 771M | |
-1.31% | 760M | |
-28.57% | 516M | |
+5.37% | 310M |
- Stock Market
- Equities
- A217330 Stock
- News Cytogen, Inc.
- TSD Life Sciences Co.,Ltd. announced that it expects to receive KRW 2.9999853 billion in funding from Cytogen, Inc.